Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03489187 · ClinicalTrials.gov registry record
Visualase Visualization Database (VIVID-1)
A clinical trial, sponsored by MedtronicNeuro.
- Completed
- Registry status
- 183
- Enrollment target
NCT03489187: Completed study, sponsored by MedtronicNeuro.
NCT03489187 is a clinical trial that has completed, run by MedtronicNeuro. The registered enrollment target is 183 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03489187 has completed, sponsored by MedtronicNeuro.
- COMPLETED
- Registry status
- 183 participants
- Enrollment target
Study Summary
The purpose of the VIVID-1 data collection study is to establish a database of clinical images and associated technical files from commercial cases using the Visualase Thermal Therapy System (VTTS). All data collected will be de-identified. No safety or effectiveness assessments will be completed.
Primary Outcome
Identify pathologies and tissue types prescribed Visualse Thermal Therapy
Interventions
- DEVICE Visualase Thermal Therapy System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2018-03-05 |
| Est. Completion | 2022-04-29 |
What the finished NCT03489187 record still lists
NCT03489187 is an observational study that tracks outcomes without assigning an intervention. The registered 183 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Visualase Thermal Therapy System is the first listed.
NCT03489187 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03489187 about?
NCT03489187 is a clinical study titled "Visualase Visualization Database (VIVID-1)". The purpose of the VIVID-1 data collection study is to establish a database of clinical images and associated technical files from commercial cases using the Visualase Thermal Therapy System (VTTS). All data collected will be de-identified. No safety or effectiveness assessments will be completed.
What is the current status of trial NCT03489187?
This trial is currently completed. The enrollment target is 183 participants. The study started on 2018-03-05. Estimated completion is 2022-04-29.
What interventions are being tested in trial NCT03489187?
The interventions under investigation include: Visualase Thermal Therapy System (DEVICE).
Who is sponsoring clinical trial NCT03489187?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03859297 · 183 participants · NA
Mechanisms of Rumination Change in Adolescent Depression
- NCT04270591 · 183 participants · Phase 1
Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer
- NCT06764615 · 183 participants · Phase 2
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- NCT06872684 · 183 participants · NA
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI